For Alzheimer's Agitation, Promising News from Rexulti (Brexpiprazole)
Por um escritor misterioso
Descrição
Rexulti (brexpiprazole) shares positive trial results for treating agitation in Alzheimer's. Following this a bumpy road for another Alzheimer's drug candidate that could supplant the need for antipsychotics to treat behavioral Alzheimer's symptoms, this could be the first such drug approved — if its safety and efficacy data stay on track.
FDA OKs First Drug for Agitation in Alzheimer's Dementia
Bioxcel shares plunge on FDA warning letter despite promising data
What medications are used to treat Alzheimer's?
Agitation in Alzheimer's: Rexulti® Makes Meaningful Improvements
Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation
FDA Panel Votes in Favor of Brexpiprazole as Potential Therapy for
JAMA Neurology Publishes Complete Results of Positive Phase 3
First-Ever Drug for Alzheimer's Agitation, Brexpiprazole, Nears
Statement on the FDA Approval of Brexpiprazole
Antipsychotic Shows Benefit for Alzheimer's Agitation
Otsuka and Lundbeck Announce REXULTI for Alzheimer's Agitation
de
por adulto (o preço varia de acordo com o tamanho do grupo)
